Cargando…
Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin
AIM: This study explored the relationship between insulin use and patient activation (a person’s internal readiness and capabilities to undertake health-promoting actions) in individuals with type 2 diabetes mellitus and aimed to identify demographic, clinical and psychosocial factors involved in pa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314047/ https://www.ncbi.nlm.nih.gov/pubmed/30643392 http://dx.doi.org/10.2147/PPA.S188391 |
_version_ | 1783384061869293568 |
---|---|
author | van Vugt, Heidi A Boels, Anne Meike de Weerdt, Inge de Koning, Eelco JP Rutten, Guy EHM |
author_facet | van Vugt, Heidi A Boels, Anne Meike de Weerdt, Inge de Koning, Eelco JP Rutten, Guy EHM |
author_sort | van Vugt, Heidi A |
collection | PubMed |
description | AIM: This study explored the relationship between insulin use and patient activation (a person’s internal readiness and capabilities to undertake health-promoting actions) in individuals with type 2 diabetes mellitus and aimed to identify demographic, clinical and psychosocial factors involved in patient activation. METHODS: In this cross-sectional study, baseline data from a Dutch nationwide study were analyzed. Patient activation was assessed with the Patient Activation Measure 13. A linear mixed model was used to take clustering into account. RESULTS: In total, 1,189 persons were included (310 of whom were on insulin), enrolled via 47 general practices and six hospitals. Their mean Patient Activation Measure 13 score was 59±12. We found no association between insulin therapy and patient activation. In the multivariable analysis, individuals with a better health status, very good or very poor social support (vs good social support), individuals who felt they had greater control over their illness and those with a better subjective understanding of their illness showed higher patient activation. Individuals with a lower educational level and those who expected their illness to continue showed a lower activation level. CONCLUSION: Patient activation does not differ between individuals with type 2 diabetes mellitus on insulin therapy and those on other therapies. |
format | Online Article Text |
id | pubmed-6314047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-63140472019-01-14 Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin van Vugt, Heidi A Boels, Anne Meike de Weerdt, Inge de Koning, Eelco JP Rutten, Guy EHM Patient Prefer Adherence Original Research AIM: This study explored the relationship between insulin use and patient activation (a person’s internal readiness and capabilities to undertake health-promoting actions) in individuals with type 2 diabetes mellitus and aimed to identify demographic, clinical and psychosocial factors involved in patient activation. METHODS: In this cross-sectional study, baseline data from a Dutch nationwide study were analyzed. Patient activation was assessed with the Patient Activation Measure 13. A linear mixed model was used to take clustering into account. RESULTS: In total, 1,189 persons were included (310 of whom were on insulin), enrolled via 47 general practices and six hospitals. Their mean Patient Activation Measure 13 score was 59±12. We found no association between insulin therapy and patient activation. In the multivariable analysis, individuals with a better health status, very good or very poor social support (vs good social support), individuals who felt they had greater control over their illness and those with a better subjective understanding of their illness showed higher patient activation. Individuals with a lower educational level and those who expected their illness to continue showed a lower activation level. CONCLUSION: Patient activation does not differ between individuals with type 2 diabetes mellitus on insulin therapy and those on other therapies. Dove Medical Press 2018-12-28 /pmc/articles/PMC6314047/ /pubmed/30643392 http://dx.doi.org/10.2147/PPA.S188391 Text en © 2019 van Vugt et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research van Vugt, Heidi A Boels, Anne Meike de Weerdt, Inge de Koning, Eelco JP Rutten, Guy EHM Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin |
title | Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin |
title_full | Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin |
title_fullStr | Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin |
title_full_unstemmed | Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin |
title_short | Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin |
title_sort | patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314047/ https://www.ncbi.nlm.nih.gov/pubmed/30643392 http://dx.doi.org/10.2147/PPA.S188391 |
work_keys_str_mv | AT vanvugtheidia patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin AT boelsannemeike patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin AT deweerdtinge patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin AT dekoningeelcojp patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin AT ruttenguyehm patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin |